name: C little s super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: C little s super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: D little o super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: D little o super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: D little r super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: E little s super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: G little y super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: J little o super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: little hr super little s Ab:PrThr:Pt:Ser/Plas:Ord


name: R little b super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: R little g super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: T little c super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: T little c super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: T little c super little b Ab:PrThr:Pt:Ser/Plas:Ord


name: T little c super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: T little c super little c Ab:Titr:Pt:Ser/Plas:SemiQn


name: W little d super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: WES super little a Ab:PrThr:Pt:Ser/Plas:Ord


name: WES super little a Ab:Titr:Pt:Ser/Plas:SemiQn


name: WES super little b Ab:Titr:Pt:Ser/Plas:SemiQn


name: Creatine, guanidinoacetate & creatinine pattern:Imp:Pt:Ser/Plas:Nar


name: Clonazepam and 7-aminoclonazepam panel:-:Pt:Ser:-


name: Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free:MRto:Pt:Ser/Plas:Qn


name: Monocyte and dendritic cell panel:-:Pt:Bld:-:Flow cytometry


name: CD3+ CD14+ CD19+CD20+ CD45+CD56+CD123+HLA-DR:NCnc:Pt:Bld:Qn:Flow cytometry


name: Mephobarbital & PHENobarbital panel:-:Pt:Bld:-


name: Phenytoin & Phenobarbital panel:-:Pt:Ser:-


name: MC5 metabolite of Tianeptine:PrThr:Pt:Plas:Ord:LC/MS/MS


name: Borrelia burgdorferi B31 Ab.IgM:PrThr:Pt:Ser:Ord:Line blot


name: Borrelia burgdorferi B31 Ab.IgG:PrThr:Pt:Ser:Ord:Line blot


name: Monkeypox virus clade II & Orthopoxvirus.non-variola DNA:Prid:Pt:XXX:Nom:Probe.amp.tar


name: DNA fragmentation index:SRto:Pt:Semen:Qn:Flow cytometry


name: High DNA stainability:NFr:Pt:Semen:Qn:Flow cytometry


name: Static oxidation-reduction potential^normalized to sperm concentration:Elpot:5M:Semen:Qn


name: Metanephrine & Normetanephrine & Total metanephrines panel:-:24H:Urine:-


name: Glucose standard deviation/Glucose mean:NFr:RptPeriod:Interstitial fluid:Qn:Calculated


name: Herpes simplex virus 1 & 2 & Varicella zoster virus & Treponema pallidum DNA panel:-:Pt:^Patient:-:Probe.amp.tar


name: Synovial Lining Cells:NCnc:Pt:Synv fld:Qn:Manual count


name: Sialate free and total panel:-:Pt:Urine:-


name: PRKACA 19p13.1 gene rearrangement:Find:Pt:Tiss:Doc:FISH


name: IgD and IgE.monocloncal band observed:Prid:Pt:Ser:Nom:Immunofixation


name: Methylphenidate & Alpha-Phenyl-2-Piperidine acetate panel:-:Pt:Urine:-


name: Parainfluenza virus 1 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Parainfluenza virus 3 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Human coronavirus NL63 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hepatitis C virus RNA:LaCnc:Pt:Ser/Plas:Qn:Molgen


name: Hepatitis C virus RNA:PrThr:Pt:Ser/Plas:Ord:Molgen


name: Parainfluenza virus 4 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Molgen


name: Influenza virus A H3 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Clostridioides difficile toxin genes:PrThr:Pt:Stool:Ord:Molgen


name: Influenza virus B RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hepatitis C virus Ab Signal/Cutoff:RelACnc:Pt:Ser/Plas:Qn


name: Epstein Barr virus DNA:NCnc:Pt:XXX:Qn:Molgen


name: Respiratory syncytial virus RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hepatitis C virus RNA:LnCnc:Pt:Ser/Plas:Qn:Molgen


name: NCBI sequence read archive number:ID:Pt:XXX:Nom


name: NCBI sequence read experiment (SRX) number:ID:Pt:XXX:Nom


name: NCBI sequence read Run (SRR) number:ID:Pt:XXX:Nom


name: NCBI Sample Accession Number:ID:Pt:XXX:Nom


name: Salmonella sp antigenic formula:ID:Pt:Isolate:Nom:Sequencing


name: Parainfluenza virus 2 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hepatitis B virus core Ab.IgM:ACnc:Pt:Ser/Plas:Qn


name: Human coronavirus HKU1 RNA:PrThr:Pt:XXX:Ord:Molgen


name: Epstein Barr virus DNA:LnCnc:Pt:XXX:Qn:Molgen


name: Lactate dehydrogenase 1/Lactate dehydrogenase.total:CFr:Pt:Urine:Qn


name: Intercellular substance & basement membrane Ab.IgA panel:-:Pt:Ser:-


name: Skin Ab.IgG:PrThr:Pt:Ser:Ord:Human split skin substrate


name: Skin Ab.IgA:PrThr:Pt:Ser/Plas:Ord:Monkey esophagus substrate


name: Skin Ab.IgA:PrThr:Pt:Ser:Ord:Human split skin substrate


name: Intercellular substance & basement membrane Ab.IgG panel:-:Pt:Ser:-


name: Observation:Prid:Pt:Cvx:Nom:Cyto stain.thin prep.computer assisted


name: Histoplasma capsulatum+Blastomyces dermatitidis Ag:PrThr:Pt:Urine:Ord:IA


name: Histoplasma capsulatum+Blastomyces dermatitidis Ag:MCnc:Pt:Urine:Qn:IA


name: Glucose dumping syndrome panel:-:Pt:Ser/Plas/Bld:-


name: Hematocrit^1H post dose glucose:VFr:Pt:Bld:Qn


name: Hematocrit^1.5H post dose glucose:VFr:Pt:Bld:Qn


name: Hematocrit^2H post dose glucose:VFr:Pt:Bld:Qn


name: Hematocrit^2.5H post dose glucose:VFr:Pt:Bld:Qn


name: Hematocrit^3H post dose glucose:VFr:Pt:Bld:Qn


name: Phosphorus.reabsorbed by renal tubules/Phosphorus.total filtered:RelRto:Pt:Urine+Ser/Plas:Ord


name: Tubular reabsorption of phosphorus panel:-:Pt:Urine+Ser/Plas:-


name: Noninvasive colorectal cancer RNA+occult blood screening:PrThr:Pt:Stool:Ord


name: Paraneoplastic vision loss evaluation panel:-:Pt:Ser:-


name: Coagulation normal/actual:RelTime:Pt:PPP:Qn:Coag.tissue factor induced.factor substitution.immediately after 1:1 addition of normal plasma.control


name: Hepatitis B virus genotype:Prid:Pt:Ser/Plas:Nom:Sequencing


name: Chloride.reabsorbed by renal tubules/Chloride.total filtered:MFr:Pt:Urine+Ser/Plas:Qn


name: Folate receptor alpha Ag:Imp:Pt:Tiss:Nar:Immune stain


name: Claudin 18 Ag:Imp:Pt:Tiss:Nar:Immune stain


name: Bacterial carbapenem resistance blaGES-11 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaGES-5 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaGIM-1 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaKPC-18 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaKPC-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaKPC-3 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaNDM-1 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaNDM-19 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaNDM-4 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaNDM-7 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaNDM-9 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA 181 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-162 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-23 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-232 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA24/40 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-244 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-58 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaOXA-72 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance ISAba1 upstream blaOXA-51 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaVIM-1 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaVIM-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial Carbapenem resistance blaVIM-4 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Coagulation:TRto:Pt:PPP^Control:Qn:Coag.surface induced.factor substitution.2H post incubation after 1:1 addition of normal plasma


name: Clostridioides difficile presence and susceptibility:Find:Pt:XXX:Doc:Organism specific culture


name: Coagulation:TRto:Pt:PPP^Control:Qn:Coag.surface induced.factor substitution.immediately after addition of normal plasma


name: Coagulation:TRto:Pt:PPP^Control:Qn:Coag.tissue factor induced.factor substitution.2H post incubation after 1:1 addition of normal plasma


name: Norovirus genogroup I+II RNA:PrThr:Pt:XXX:Ord


name: Streptococcus pyogenes exotoxin B speB gene:PrThr:Pt:XXX:Ord


name: Shigella species+EIEC invasion plasmid antigen H (ipaH) gene:PrThr:Pt:XXX:Ord


name: SARS coronavirus+SARS coronavirus 2 Ag:PrThr:Pt:XXX:Ord


name: Escherichia coli Stx1+Stx2 toxin stx1+stx2 genes:PrThr:Pt:Stool:Ord


name: Escherichia coli shiga-like toxin 1 & 2:Prid:Pt:Stool:Nom


name: Escherichia coli enterotoxigenic ltA+st1a+st1b genes:PrThr:Pt:Stool:Ord


name: Megasphaera sp type 1 DNA:PrThr:Pt:XXX:Ord


name: Legionella pneumophila 1 Ag:PrThr:Pt:XXX:Ord


name: Influenza virus A H1 RNA:PrThr:Pt:XXX:Ord


name: Human coronavirus OC43 RNA:PrThr:Pt:XXX:Ord


name: Human coronavirus 229E RNA:PrThr:Pt:XXX:Ord


name: HIV 1+2 Ab+HIV1 p24 Ag:PrThr:Pt:Ser/Plas:Ord


name: Histoplasma capsulatum+Blastomyces dermatitidis Ag panel:-:Pt:Urine:-:IA


name: Lysosomal storage disorders screen panel:-:Pt:Urine:-


name: Offspring or Inheritance risk:Likelihood:Pt:^Newborn:Nar:Molgen


name: Invasive Trophoblast Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Treponema pallidum Ab.IgG Index:ACnc:Pt:Ser+CSF:Qn


name: Inflammatory Bowel Disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary nonpolyposis colorectal cancer multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Marfan and related conditions multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Noonan syndrome and related conditions multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Fentanyl & Norfentanyl panel:-:Pt:Bld:-:LC/MS/MS


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Sputum:Ord:Probe.amp.tar


name: Respiratory syncytial virus RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Influenza virus A+B RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Parainfluenza virus 2 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Parainfluenza virus 4 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Mycobacterium sp:Prid:Pt:Pericard fld:Nom:Organism specific culture


name: Mycobacterium sp:Prid:Pt:Pus:Nom:Organism specific culture


name: Respiratory syncytial virus RNA:PrThr:Pt:Sputum:Ord:Probe.amp.tar


name: Influenza virus A+B RNA:PrThr:Pt:Sputum:Ord:Probe.amp.tar


name: Influenza virus A RNA:PrThr:Pt:Sputum:Ord:Probe.amp.tar


name: Influenza virus B RNA:PrThr:Pt:Sputum:Ord:Probe.amp.tar


name: Glycogen storage disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Ketone disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Lysosomal storage disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Peroxisomal disorder multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Tyrosine disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Urea cycle disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Fractional excretion of calcium:Ratio:XXX:Urine+Ser/Plas:Qn


name: Platelet aggregation:RelACnc:Pt:PRP:Qn:Aggregometry.collagen induced.190 ug/mL


name: Neutrophil membrane Ab:PrThr:Pt:Ser/Plas:Ord:Flow cytometry


name: Programmed cell death ligand 1 scoring method:Type:Pt:Tiss:Nom:Immune stain


name: Tumor cells+Macrophages+Lymphocytes.Programmed cell death ligand 1/Viable tumor cells:Ratio:Pt:Tiss:Qn:Immune stain


name: Tumor cells.Programmed cell death ligand 1/Viable tumor cells:NFr:Pt:Tiss:Qn:Immune stain


name: Tumor area infiltrated with PD-L1 expressing immune cells/Total tumor area:AreaFr:Pt:Tiss:Qn:Immune stain


name: Glial fibrillary acidic protein:MCnc:Pt:Bld:Qn:IA


name: Hereditary angioedema multigene analysis:Find:Pt:Bld:Doc:Molgen


name: Hereditary bleeding disorders multigene analysis:Find:Pt:XXX:Doc:Molgen


name: Hereditary bleeding disorders factor and von Willebrand multigene analysis:Find:Pt:XXX:Doc:Molgen


name: MYH9 gene full mutation analysis:Find:Pt:Bld:Doc:Molgen


name: Hereditary platelet function defect multigene analysis:Find:Pt:Bld:Doc:Molgen


name: Hereditary platelet disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary platelet storage pool deficiency multigene analysis:Find:Pt:Bld:Doc:Molgen


name: Hereditary thrombosis disorders multigene analysis:Find:Pt:Bld:Doc:Molgen


name: Chlamydia trachomatis L1 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Chlamydia trachomatis L3 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: 2-Hydroxyglutarate aciduria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: 3-Methylglutaconate aciduria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Acute myeloid Leukemia multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Acute porphyria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Glycosylation congenital disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Methylmalonate aciduria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Methylmalonate aciduria-propionic aciduria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Neuronal ceroid lipofuscinosis multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hereditary erythrocytosis multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Congenital lactic acidosis multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Fatty acid oxidation multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Glutarate aciduria 2 multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Maple syrup urine disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Human coronavirus OC43 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Human coronavirus HKU1 RNA:PrThr:Pt:Nph:Ord:Probe.amp.tar


name: Lysosomal and peroxisomal storage disorders panel:-:Pt:Bld.dot:-


name: Tripartite motif containing 46 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Tripartite motif containing 46 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Tripartite motif containing 46 Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Butyryl fentanyl carboxy metabolite:MCnc:Pt:Urine:Qn


name: Rheumatoid arthritis disease activity:Score:Pt:Ser/Plas:Ord


name: Rheumatoid arthritis disease risk score:Score:Pt:^Patient:Ord


name: U2 small nuclear ribonucleoprotein Ab:ACnc:Pt:Ser:Qn


name: Signal recognition particle Ab:ACnc:Pt:Ser:Ord


name: U1 small nuclear ribonucleoprotein Ab:ACnc:Pt:Ser:Qn


name: Sjogrens syndrome-A extractable nuclear 52kD Ab.IgG:ACnc:Pt:Ser:Qn


name: SUMO-activating enzyme subunit 1 Ab.IgG:ACnc:Pt:Ser:Qn


name: DICER1 gene full mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: H3 Clustered Histone 14 gene targeted mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: IDH1 gene & IDH2 gene & TERT gene targeted mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: Adult type diffuse glioma gene targeted mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: Bladder & Prostate cancer multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Endometrial carcinoma multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Renal cell carcinoma fibromyomatous stroma multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Gynecological carcinoma multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Renal cell carcinoma multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: Ovarian, fallopian tube and peritoneal carcinoma multigene analysis:Find:Pt:Tiss:Doc:Molgen


name: MYOD1 targeted gene mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: NTRK1 & NTRK2 & NTRK3 targeted gene mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: POLE targeted gene mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: SDHA & SDHB & SDHC & SDHD targeted gene mutation analysis:Find:Pt:Tiss:Doc:Molgen


name: Aeromonas sp:Prid:Pt:XXX:Nom:Organism specific culture


name: Campylobacter & Salmonella & Shigella sp^^^2:Prid:Pt:Stool:Nom:Organism specific culture


name: Campylobacter & Salmonella & Shigella sp^^^3:Prid:Pt:Stool:Nom:Organism specific culture


name: Aeromonas sp:PrThr:Pt:Stool:Ord:Organism specific culture


name: Acinetobacter calcoaceticus-baumannii complex DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Burkholderia cepacia complex DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Citrobacter freundii complex DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Enterobacter cloacae complex DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Klebsiella variicola subsp. tropica DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Yersinia pseudotuberculosis complex DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A+B RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Parainfluenza virus 1 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Parainfluenza virus 2 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Parainfluenza virus 3 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Parainfluenza virus 4 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Human bocavirus 1+2+3+4 DNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Epstein Barr virus DNA:PrThr:Pt:Pericard fld:Ord:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Pericard fld:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:PrThr:Pt:Pericard fld:Ord:Probe.amp.tar


name: Parvovirus B19 DNA:PrThr:Pt:Pericard fld:Ord:Probe.amp.tar


name: Herpes virus 6 DNA:PrThr:Pt:Skin:Ord:Probe.amp.tar


name: SARS coronavirus 2 RNA:PrThr:Pt:Tracheal aspirate:Ord:Probe.amp.tar


name: SARS coronavirus 2 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Lactose challenge panel-methane:-:Pt:Exhl gas:-


name: Lactose challenge panel-hydrogen:-:Pt:Exhl gas:-


name: Reduction in clot strength^30M after maximum clot amplitude:LenFr:Pt:Bld:Qn:Thromboelastography.resonance.kaolin induced.post heparin neutralization


name: Maximum clot strength amplitude:Len:Pt:Bld:Qn:Thromboelastography.resonance.kaolin.tissue factor induced.post heparin neutralization


name: Maximum clot strength amplitude:Len:Pt:Bld:Qn:Thromboelastography.resonance.tissue factor induced with platelet glycoprotein IIb-IIIa receptor inhibited.post heparin neutralization


name: Mycobacterium tuberculosis.rrs gene kanamycin high level resistant mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis eis gene mutations:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis embC-embA promoter region gene ethambutol resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis mabA gene ethionamide resistance mutation:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Mycobacterium tuberculosis mabA gene INH high level resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis mabA promoter region gene ethionamide resistance mutation:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Mycobacterium tuberculosis mabA promoter region gene INH high level resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis oxyR-ahpC promoter region gene INH high level resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis pncA promoter region gene pyrazinamide resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Enterobacter spp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Escherichia coli DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Klebsiella spp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Proteus sp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Salmonella spp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Serratia spp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Pseudomonas aeruginosa DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Neisseria meningitidis DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Haemophilus influenzae DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Acinetobacter calcoaceticus-baumannii complex DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacteroides fragilis DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Stenotrophomonas maltophilia DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Aminoglycoside 6'-N-acetyltransferase type Ib gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance AmpC blaCMY+blaLAT+blaDHA+blaFOX gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial aminoglycoside resistance ArmA gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial cephalosporin resistance blaCTX-M gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaGES gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaIMP gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaKPC gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaNDM gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-23 gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-48-like gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-58:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Pseudomonas aeruginosa regA gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance ESBL blaSHV gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance SPM gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaTEM gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial beta-lactam resistance blaVEB gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaVIM gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Micrococcus spp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Staphylococcus aureus DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Staphylococcus epidermidis DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Staphylococcus lugdunensis DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Staphylococcus capitis+Staphylococcus hominis DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Streptococcus agalactiae DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Streptococcus anginosus group DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Streptococcus pneumoniae DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Streptococcus pyogenes DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Cryptococcus gattii+neoformans DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Fusarium sp DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Candida auris DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Aac(6') aph(2') gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial macrolide resistance ErmA gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial macrolide resistance ErmC gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial antimicrobial resistance mecA gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial methicillin resistance mecC gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial tetracycline resistance tetK gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial tetracycline resistance tetM gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial vancomycin resistance vanA gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Bacterial vancomycin resistance vanB gene:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Clostridioides difficile toxin A+B tcdA+tcdB genes:PrThr:Pt:Stool:Ord


name: Epidermal growth factor receptor Ag:PrThr:Pt:XXX:Ord


name: Calcium oxalate crystals:Naric:Pt:Urine sed:Qn


name: Bacterial vaginosis associated bacterium 2 DNA:PrThr:Pt:Vag:Ord


name: Astrovirus subtypes 1-8 RNA:PrThr:Pt:Stool:Ord


name: Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes:PrThr:Pt:Stool:Ord


name: SARS coronavirus 2 Ab.IgG:ACnc:Pt:XXX:Qn


name: SARS coronavirus 2 Ab.IgG:PrThr:Pt:XXX:Ord


name: Sapovirus genogroups I+II+IV+V RNA:PrThr:Pt:XXX:Ord


name: Microscopic observation^2nd specimen:Prid:Pt:Bld:Nom:Gram stain


name: Mycobacterium sp:Prid:Pt:Stool:Nom:Organism specific culture


name: Microscopic observation^3rd specimen:Prid:Pt:Bld:Nom:Gram stain


name: Microscopic observation^2nd specimen:Prid:Pt:Ctp:Nom:Gram stain


name: Microscopic observation^3rd specimen:Prid:Pt:Ctp:Nom:Gram stain


name: RUNX1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Multiple myeloma minimal residual disease analysis:PrThr:Pt:Bone mar:Ord:Non-probe.amp.tar


name: Varicella zoster virus DNA:PrThr:Pt:Genital:Ord:Probe.amp.tar


name: Chlamydia trachomatis DNA:Prid:Pt:Periton fld:Nom:Probe.amp.tar


name: Staphylococcus aureus.methicillin resistant isolate:PrThr:Pt:Skin:Ord:Organism specific culture


name: Staphylococcus aureus.methicillin resistant isolate:PrThr:Pt:Axilla:Ord:Organism specific culture


name: Human papilloma virus 35+39+51+56+59+66+68 DNA:PrThr:Pt:Cvx:Ord:Probe.amp.tar


name: Postmortem aortopathy multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Beta-Amyloid 1-42 and 1-40 panel:-:Pt:CSF:-


name: Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel:-:Pt:Vagina:-:Probe.amp.tar


name: Hepatitis B and C virus Ab panel:-:Pt:Ser:-:Probe.amp.tar


name: HBG1 gene mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HBG2 gene mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:Asp:Ord:Probe.amp.tar


name: Human coronavirus NL63 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Human coronavirus OC43 RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Human bocavirus 1+2+3+4 DNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Respiratory syncytial virus A RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Respiratory syncytial virus B RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: Candida albicans+tropicalis+dubliniensis+famata+guilliermondii+kefyr DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Candida glabrata+krusei+parapsilosis+lusitanieae DNA:ThreshNum:Pt:Bld.pos growth:Qn:Probe.amp.tar


name: Cells.recipient derived/Cells^post stem cell transplantation:NFr:Pt:Bone mar:Qn:Molgen


name: T little c super little c Ab:PrThr:Pt:Ser/Plas:Ord


name: Influenza virus A H1 2009 pandemic RNA:PrThr:Pt:XXX:Ord:Molgen


name: Hematocrit^30M post dose glucose:VFr:Pt:Bld:Qn


name: Bacterial Carbapenem resistance blaNDM-5 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Human papilloma virus DNA:PrThr:Pt:XXX:Ord


name: Influenza virus B RNA:PrThr:Pt:Bronchial:Ord:Probe.amp.tar


name: Phenylalanine disorders multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: VWF and GP1BA gene mutation analysis:Find:Pt:XXX:Doc:Molgen


name: Tripartite motif containing 46 Ab.IgG:PrThr:Pt:CSF:Ord:IF


name: Rheumatoid arthritis disease activity risk category:Score:Pt:Ser/Plas:Ord


name: Bordetella parapertussis DNA:PrThr:Pt:Respiratory system specimen.lower:Ord:Probe.amp.tar


name: Human coronavirus 229E+HKU1+NL63+OC43 RNA:PrThr:Pt:BAL:Ord:Probe.amp.tar


name: DNMT3A gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: MPXV clade II not detected, non-variola OPXV not detected


name: Awake; cooperative, oriented, and tranquil


name: Asleep; brisk response to light glabellar tap or loud auditory stimulus


name: Asleep; sluggish response to light glabellar tap or loud auditory stimulus


name: Asleep; no response to glabellar tap or loud auditory stimulus


name: Medicine A and medicine B work equally well


name: Medicine A is proven to be better than medicine B


name: Medicine B is proven to be better than medicine A


name: There is a relationship between exercising and living longer


name: ETDRS Level 20 or lower, without macular edema


name: Insufficient image quality to support autonomous analysis


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.19.1:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Nursing home comprehensive (NC) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: Is the resident's COVID-19 vaccination up to date?:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.left:Doc:US


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.right:Doc:US


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.bilateral:Doc:US


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.left:Doc:US.doppler


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.right:Doc:US.doppler


name: Multisection for transplanted kidney:Find:Pt:Abdomen>Kidney.bilateral:Doc:US.doppler


name: Cerebrospinal fluid chemistry report:Find:Pt:^Patient:Doc


name: Body fluid chemistry report:Find:Pt:^Patient:Doc


name: Human platelet antigen report:Find:Pt:^Patient:Doc


name: Human neutrophil antigen report:Find:Pt:^Patient:Doc


name: Admission history and physical note:Find:Pt:{Setting}:Doc:Hospitalist


name: MDS v3.0 - RAI v1.19.1 - Nursing home PPS (NP) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Nursing home quarterly (NQ) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: What kind of work was this person doing:Find:Pt:^Patient:Nom:PhenX


name: What were this person's most important activities or duties:Find:Pt:^Patient:Nom:PhenX


name: Plan of care note:Find:Pt:{Setting}:Doc:Breastfeeding


name: Plan of care note:Find:Pt:{Setting}:Doc:Burn management


name: Plan of care note:Find:Pt:{Setting}:Doc:Clinical neurophysiology


name: Plan of care note:Find:Pt:{Setting}:Doc:Rapid response team


name: Plan of care note:Find:Pt:{Setting}:Doc:Hospitalist


name: Consultation note:Find:Pt:Telephone encounter:Doc:Gynecologic oncology


name: Note:Find:Pt:Telephone encounter:Doc:Child and adolescent psychiatry


name: Note:Find:Pt:Telehealth:Doc:Child and adolescent psychiatry


name: Note:Find:Pt:Telehealth:Doc:Medical aid in dying


name: MDS v3.0 - RAI v1.19.1 - Nursing home discharge (ND) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: Medication overridden safety advice:Find:Pt:Medication:Nar


name: Medication exceptional safety override:Find:Pt:^Patient:Nar


name: Medication total daily effective dose:Dosage:Pt:Medication:Qn


name: Medication maximum dose allowed period:Time:Pt:Medication:Qn


name: Medication dispense expiry date:Date:Pt:Medication:Qn


name: Medication administration specific directions:Find:Pt:^Patient:Nar


name: Medication total daily amount:Num:24H:Medication:Qn


name: Medication dispense start date:Date:Pt:Medication:Qn


name: Medication maximum dose amount:Num:Pt:Medication:Qn


name: Medication strength presentation information:-:Pt:Medication:-


name: Multisection metabolic^W radionuclide IV:Find:Pt:Chest>Heart:Doc:PT+CT


name: Equine acute pain scale:Imp:Pt:^Animal:Ord


name: Feline acute pain scale:Imp:Pt:^Animal:Ord


name: Number of potentially affected by condition:Num:Pt:^Family member:Qn


name: Language of communication information:Type:Pt:Person:Nom


name: Communication phone number or email address:EmailAddr:Pt:Person:Nom


name: Family member problem:Type:Pt:^Family member:Nar


name: Multisection for bone density:MCnc:Pt:Spine:Qn:CT


name: Views for bone density:Tscore:Pt:Spine:Qn:DXA


name: Multisection for bone density:MCnc:Pt:Hip:Qn:CT


name: Multisection for bone density:ArMass:Pt:Hip:Qn:CT


name: Multisection for bone density:Tscore:Pt:Hip:Qn:CT


name: Multisection for bone density:Zscore:Pt:Hip:Qn:CT


name: Multisection for bone density:MCnc:Pt:Femur:Qn:CT


name: Multisection for bone density:ArMass:Pt:Femur:Qn:CT


name: Multisection for bone density:Tscore:Pt:Femur:Qn:CT


name: Multisection for bone density:Zscore:Pt:Femur:Qn:CT


name: Cause of death indicator:Find:Pt:Person:Nom


name: Communication capability per language:Find:Pt:Person:Nar


name: Medical device summary information:Pn:Pt:^Patient:Nar


name: Problem family prevalence description:Find:Pt:^Patient:Nar


name: Resource identifier for device:URI:Pt:{Device}:Nar


name: Diameter:Len:Pt:Left main coronary artery:Qn:US


name: Pressure gradient.max:PressDiff:Pt:Patent ductus arteriosis:Qn:US


name: Pressure gradient.mean:PressDiff:Pt:Patent ductus arteriosis:Qn:US


name: MDS v3.0 - RAI v1.19.1 - Nursing home and Swing bed tracking (NT ST) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: Ramsay sedation scale total score:Score:Pt:^Patient:Qn:Reported.RSS


name: Cosmetic update:-:-:^FDA product label:Nar


name: Multisection^W contrast IV:Find:Pt:Abdomen>Liver+Biliary ducts+Pancreas:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Head>Brain:Doc:MR.perfusion


name: Multisection^W contrast IV:Find:Pt:Lower extremity.left>Lower extremity vessels:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:MR.angio


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.bilateral>Lower extremity vessels:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Pelvis>Pelvis veins:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Abdomen>Abdominal veins:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Aortic arch:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Head>Head vessels & Neck>Neck vessels:Doc:MR.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head>Head vessels & Neck>Neck vessels:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.left>Upper extremity vessels:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.right>Upper extremity vessels:Doc:MR.angio


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:MR.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:MR.angio


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity veins:Doc:MR.angio


name: Multisection^W contrast PO+W contrast IV:Find:Pt:Abdomen>Small bowel:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Pelvis>Lumbosacral plexus:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Pelvis>Lumbosacral plexus:Doc:MR


name: Multisection^WO contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity joint:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity joint:Doc:MR


name: Multisection^during surgery W contrast IV:Find:Pt:Head>Brain:Doc:MR


name: Multisection^during surgery WO & W contrast IV:Find:Pt:Head>Brain:Doc:MR


name: Guidance for percutaneous biopsy:Find:Pt:Breast:Doc:MR


name: Multisection cine for function^WO contrast:Find:Pt:Chest>Heart:Doc:MR


name: Multisection cine for function^WO & W contrast IV:Find:Pt:Chest>Heart:Doc:MR


name: Multisection cine for function^W contrast IV:Find:Pt:Chest>Heart:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Heart:Doc:MR.angio


name: Multisection cine for blood flow velocity mapping^WO & W contrast IV:Find:Pt:Chest>Heart:Doc:MR


name: Functional assessment standardized items (FASI) - v1.1:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.19.1 - Nursing home part A PPS discharge (NPE) item set:-:RptPeriod:^Patient:-:CMS Assessment


name: Half of daily AQI values were less than or equal to the median value, and half equaled or exceeded it:Num:Pt:^Patient:Qn


name: Interpretation of canine acute pain scale:Imp:Pt:^Animal:Nar


name: Did a doctor or other health provider give you instructions about what to do about a specific illness or health condition:Find:12Mo:^Patient:Ord


name: How often were these instructions easy to understand:Find:12Mo:^Patient:Ord


name: How often did doctors or other health providers ask you to describe how you were going to follow these instructions:Find:12Mo:^Patient:Ord


name: Did you have to fill out or sign any forms at a doctor or other health provider office:Find:12Mo:^Patient:Ord


name: How often were you offered help in filling out a form at the doctors or other health providers office:Find:12Mo:^Patient:Ord


name: How often did doctors or other health professionals explain things in a way that was easy to understand:Find:12Mo:^Patient:Ord


name: How often did doctors or other health professionals listen carefully to you:Find:12Mo:^Patient:Ord


name: How often did doctors or other health professionals show respect for what you had to say:Find:12Mo:^Patient:Ord


name: How often did doctors or other health professionals spend enough time with you:Find:12Mo:^Patient:Ord


name: Did you make any appointments to see a specialist:Find:12Mo:^Patient:Ord


name: How often did you get an appointment to see a specialist as soon as you needed:Find:12Mo:^Patient:Ord


name: Patients who have exercise habits and followed them over time 3 times a week or more lived an average of 2Y longer than those who did not:Find:3W:^Patient:Ord


name: Diabetic retinopathy screening:Find:Pt:Eye:Ord:Autonomous artificial intelligence


name: Green wine glasses per W:Num:Pt:^Patient:Qn


name: Mature wine glasses per W:Num:Pt:^Patient:Qn


name: Aperitif drinks per W:Num:Pt:^Patient:Qn


name: Glasses of water per D:Num:Pt:^Patient:Qn


name: Racial and ethnic minority status:Prctl:RptPeriod:^Patient:Qn


name: National socioeconomic disadvantage rank:Prctl:RptPeriod:^Patient:Qn


name: State socioeconomic disadvantage rank:Score:RptPeriod:^Patient:Qn


name: Population with no social vulnerability factors:Num:RptPeriod:^Community:Qn


name: Census tract medically underserved area:Score:RptPeriod:^Patient:Qn:Calculated


name: Medically underserved county area:Score:RptPeriod:^Community:Qn:Calculated


name: Overall social vulnerability index:Prctl:RptPeriod:^Patient:Qn


name: Index housing type and transportation:Prctl:RptPeriod:^Patient:Qn


name: Ventilator Liberation Rate:-:RptPeriod:^Patient:-:CMS Assessment


name: Guidance for aspiration:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:US


name: Guidance for aspiration:Find:Pt:Pelvis & Lower extremity.left>Hip:Doc:US


name: Guidance for biopsy:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:US


name: Guidance for aspiration:Find:Pt:Pelvis & Lower extremity.right>Hip:Doc:US


name: Guidance for aspiration:Find:Pt:Lower extremity.left>Knee:Doc:US


name: Guidance for biopsy:Find:Pt:Lower extremity.right>Knee:Doc:US


name: Guidance for aspiration:Find:Pt:Lower extremity.right>Knee:Doc:US


name: Guidance for biopsy:Find:Pt:Lower extremity.left>Tibia+Fibula:Doc:US


name: Guidance for microwave ablation:Find:Pt:XXX:Doc:US


name: Guidance for placement of non-tunneled central venous catheter:Find:Pt:XXX:Doc:US


name: Guidance for placement of non-tunneled central venous catheter:Find:Pt:Lower extremity>Femoral vein:Doc:US


name: Guidance for drainage+placement of drainage catheter:Find:Pt:Neck:Doc:US


name: Guidance for radiofrequency ablation:Find:Pt:Abdomen>Liver:Doc:US


name: Guidance for aspiration:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:US


name: Guidance for biopsy:Find:Pt:Upper extremity.left>Shoulder:Doc:US


name: Guidance for aspiration:Find:Pt:Upper extremity.left>Shoulder:Doc:US


name: Guidance for biopsy:Find:Pt:Upper extremity.right>Shoulder:Doc:US


name: Guidance for aspiration:Find:Pt:Upper extremity.right>Shoulder:Doc:US


name: Guidance for biopsy:Find:Pt:Lower extremity.left>Femur:Doc:US


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Chest>Axilla.left:Doc:US


name: Guidance for aspiration.fine needle:Find:Pt:Chest>Axilla.right:Doc:US


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Upper extremity.right>Shoulder:Doc:US


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity veins:Doc:US.doppler


name: Guidance for aspiration:Find:Pt:Upper extremity.bilateral>Elbow:Doc:US


name: Guidance for biopsy:Find:Pt:Upper extremity.left>Elbow:Doc:US


name: Guidance for biopsy:Find:Pt:Upper extremity.right>Elbow:Doc:US


name: Guidance for placement of fiducial marker:Find:Pt:Abdomen>Liver:Doc:US


name: Guidance for biopsy:Find:Pt:Lower extremity.left>Foot:Doc:US


name: Guidance for biopsy:Find:Pt:Lower extremity.right>Foot:Doc:US


name: Guidance for aspiration.fine needle:Find:Pt:Chest>Clavicle.left:Doc:US


name: Guidance for aspiration.fine needle:Find:Pt:Pelvis>Groin.left:Doc:US


name: Guidance for aspiration.fine needle:Find:Pt:Pelvis>Groin.right:Doc:US


name: Guidance for biopsy:Find:Pt:Upper extremity.left>Hand:Doc:US


name: Thoughts on life sustaining treatment:Find:Pt:^Patient:Nar:Reported


name: Lactate dehydrogenase 1/Lactate dehydrogenase.total|CFr|Urine


name: MR.angio|Upper extremity vessels|Multisection^W contrast IV|Laterality:ANY


name: MR.angio|Upper extremity vessels|Multisection^WO contrast IV|Laterality:ANY


name: US.doppler|Kidney|Multisection for transplanted kidney|Laterality:ANY


name: US|Kidney|Multisection for transplanted kidney|Laterality:ANY


name: No harm related to unintentional sterile field


name: Static oxidation-reduction potential^normalized to sperm concentration


name: Tumor area infiltrated with PD-L1 expressing immune cells


name: Multisection^during surgery W contrast IV


name: Multisection^during surgery WO & W contrast IV


name: Multisection cine for function^WO contrast


name: Multisection cine for function^WO & W contrast IV


name: Multisection cine for function^W contrast IV


name: Multisection cine for blood flow velocity mapping^WO contrast IV


name: Multisection cine for blood flow velocity mapping^WO & W contrast IV


name: Tumor cells+Macrophages+Lymphocytes.Programmed cell death ligand 1


name: Tumor cells and Macrophages and Lymphocytes


name: Feeling down, depressed, irritable, or hopeless


name: Clostridioides difficile presence and susceptibility | XXX | Microbiology


name: Fungal ITS region | Specimen | Microbiology


name: Observation | Amniotic fluid | Microbiology


name: Observation | Bronchoalveolar lavage | Microbiology


name: Observation | Blood or Marrow | Microbiology


name: Observation | Bone marrow | Microbiology


name: Observation | Contact lens | Microbiology


name: Observation | Cornea or Conjunctiva | Microbiology


name: Observation | Cerebral spinal fluid | Microbiology


name: Observation | Catheter tip | Microbiology


name: Observation | Dialysis fluid | Microbiology


name: Observation | Dialysis fluid peritoneal | Microbiology


name: Observation | Duodenal fluid | Microbiology


name: Observation | Endometrium | Microbiology


name: Observation | Gastric fluid | Microbiology


name: Observation | Genital fluid | Microbiology


name: Observation | Genital mucus | Microbiology


name: Observation | Implanted device | Microbiology


name: Observation | Nasopharynx | Microbiology


name: Observation | Ocular fluid | Microbiology


name: Observation | Pericardial fluid | Microbiology


name: Observation | Peritoneal fluid | Microbiology


name: Observation | Pleural fluid | Microbiology


name: Observation | Lower respiratory specimen | Microbiology


name: Observation | Upper respiratory specimen | Microbiology


name: Observation | Synovial fluid | Microbiology


name: Observation | Tissue and Smears | Microbiology


name: NCBI sequence read Run (SRR) number | XXX | Microbiology


name: NCBI sequence read experiment (SRX) number | XXX | Microbiology


name: NCBI sequence read archive number | XXX | Microbiology


name: NCBI Sample Accession Number | XXX | Microbiology


name: NCBI BioProject identifier | XXX | Microbiology


name: Borrelia afzelii+burgdorferi+garinii IgG and IgM panel | Serum or Plasma | Microbiology Panels


name: Aztreonam+Avibactam | Isolate | Antibiotic susceptibilities


name: Clofazimine+Amikacin | Isolate | Antibiotic susceptibilities


name: Bacterial resistance panel | Isolate | Antibiotic Susceptibility Panels


name: 1,1-Dimethoxyhexadecane/palmitate | DBS | Chemistry - non-challenge


name: 1,1-Dimethoxyoctadecane/octadecanoate | DBS | Chemistry - non-challenge


name: Creatine/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Guanidinoacetate/Creatinine | Serum or Plasma | Chemistry - non-challenge


name: Creatine, guanidinoacetate and creatinine pattern | Serum or Plasma | Chemistry - non-challenge


name: Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free | Serum or Plasma | Chemistry - non-challenge


name: IgD and IgE.monocloncal band observed | Serum | Chemistry - non-challenge


name: Rheumatoid arthritis disease activity | Serum or Plasma | Chemistry - non-challenge


name: Rheumatoid arthritis disease risk score | Patient | Chemistry - non-challenge


name: Rheumatoid arthritis disease activity risk category | Serum or Plasma | Chemistry - non-challenge


name: Time below range, very low | Interstitial fluid | Chemistry - non-challenge


name: Ambulatory glucose profile | Interstitial fluid | Chemistry - non-challenge


name: Time hypoglycemic | Interstitial fluid | Chemistry - non-challenge


name: Time above range, high | Interstitial fluid | Chemistry - non-challenge


name: Time above range, very high | Interstitial fluid | Chemistry - non-challenge


name: Glucose standard deviation / Glucose mean | Interstitial fluid | Chemistry - non-challenge


name: Carnitine free and total and acylcarnitine panel | Urine | Chemistry Panels


name: Creatine, guanidinoacetate and creatinine panel | Serum or Plasma | Chemistry Panels


name: Dimethylacetal (DMA) panel | DBS | Chemistry Panels


name: Immunoglobulin light chains.free panel | Serum or Plasma | Chemistry Panels


name: Lactose challenge panel-hydrogen | Exhaled gas | Challenge Bank Panels


name: Sunitinib and N-Desethyl Sunitinib | Serum or Plasma | Drug toxicology


name: fentaNYL and Norfentanyl panel | Blood | Drug and Toxicology Panels


name: Mephobarbital and PHENobarbital panel | Blood | Drug and Toxicology Panels


name: Sperm attachment site | Semen | Fertility testing


name: Sperm agglutination level | Semen | Fertility testing


name: Sperm agglutination | Semen | Fertility testing


name: Static oxidation-reduction potential | Semen | Fertility testing


name: DNA fragmentation index | Semen | Molecular pathology


name: Cystinuria multigene analysis | Blood or Tissue | Molecular pathology


name: SDHA and SDHB and SDHC and SDHD targeted gene mutation analysis | Tissue and Smears | Molecular pathology


name: Renal cell carcinoma multigene analysis | Tissue and Smears | Molecular pathology


name: Renal cell carcinoma fibromyomatous stroma multigene analysis | Tissue and Smears | Molecular pathology


name: POLE targeted gene mutation analysis | Tissue and Smears | Molecular pathology


name: Ovarian, fallopian tube and peritoneal carcinoma multigene analysis | Tissue and Smears | Molecular pathology


name: NTRK1 and NTRK2 and NTRK3 targeted gene mutation analysis | Tissue and Smears | Molecular pathology


name: MYOD1 targeted gene mutation analysis | Tissue and Smears | Molecular pathology


name: Multiple myeloma minimal residual disease analysis | Bone marrow | Molecular pathology


name: CYP2B6 Activity Score | Blood or Tissue | Molecular pathology


name: CYP2C19 Activity Score | Blood or Tissue | Molecular pathology


name: CYP2C9 Activity Score | Blood or Tissue | Molecular pathology


name: CYP2D6 Activity Score | Blood or Tissue | Molecular pathology


name: DPYD Activity Score | Blood or Tissue | Molecular pathology


name: Noninvasive prenatal testing overall interpretation | Fetus | Molecular pathology


name: Noninvasive colorectal cancer RNA and occult blood screening | Stool | Molecular pathology


name: Noninvasive prenatal testing comment | Fetus | Molecular pathology


name: VWF and GP1BA gene mutation analysis | XXX | Molecular pathology


name: Urea cycle disorders multigene analysis | Blood or Tissue | Molecular pathology


name: Tyrosine disorders multigene analysis | Blood or Tissue | Molecular pathology


name: Postmortem aortopathy multigene analysis | Blood or Tissue | Molecular pathology


name: Porphyria multigene analysis | Blood or Tissue | Molecular pathology


name: Phenylalanine disorders multigene analysis | Blood or Tissue | Molecular pathology


name: Peroxisomal disorder multigene analysis | Blood or Tissue | Molecular pathology


name: Offspring or Inheritance risk | Newborn | Molecular pathology


name: Noonan syndrome and related conditions multigene analysis | Blood or Tissue | Molecular pathology


name: Neuronal ceroid lipofuscinosis multigene analysis | Blood or Tissue | Molecular pathology


name: Methylmalonate aciduria-propionic aciduria multigene analysis | Blood or Tissue | Molecular pathology


name: Methylmalonate aciduria multigene analysis | Blood or Tissue | Molecular pathology


name: Marfan and related conditions multigene analysis | Blood or Tissue | Molecular pathology


name: Maple syrup urine disease multigene analysis | Blood or Tissue | Molecular pathology


name: Lysosomal storage disease multigene analysis | Blood or Tissue | Molecular pathology


name: Lung cancer screening | Plasma cell-free DNA | Molecular pathology


name: Ketone disorders multigene analysis | Blood or Tissue | Molecular pathology


name: High DNA stainability | Semen | Molecular pathology


name: Hereditary thrombosis disorders multigene analysis | Blood | Molecular pathology


name: Hereditary platelet storage pool deficiency multigene analysis | Blood | Molecular pathology


name: Hereditary platelet function defect multigene analysis | Blood | Molecular pathology


name: Hereditary platelet disorders multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary nonpolyposis colorectal cancer multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary erythrocytosis multigene analysis | Blood or Tissue | Molecular pathology


name: Hereditary bleeding disorders multigene analysis | XXX | Molecular pathology


name: Hereditary bleeding disorders factor and von Willebrand multigene analysis | XXX | Molecular pathology


name: Lymph node involvement | Tissue and Smears | Pathology


name: Mitotic rate | Tissue and Smears | Pathology


name: Paraneoplastic vision loss | XXX | Serology - non-micro


name: Beta-Amyloid 1-42 and 1-40 panel | Cerebral spinal fluid | Serology - non-micro


name: SP100 and GP210 Ab.IgG panel | Serum or Plasma | Serology - non-micro


name: Xanthochromia | XXX | Specimen information


name: Collection end time | XXX | Specimen information


name: Consistency | Urine | Specimen information


name: Tube number | XXX | Specimen information


name: Authenticity information | {Setting} | Document ontology


name: Diameter | Anterior descending artery.left | Cardiac ultrasound


name: Diameter | Circumflex artery.left | Cardiac ultrasound


name: Diameter | Coronary artery.right | Cardiac ultrasound


name: Diameter | Left main coronary artery | Cardiac ultrasound


name: Gradient maximum | Patent ductus arteriosis | Cardiac ultrasound


name: Gradient maximum | Left pulmonary artery | Cardiac ultrasound


name: Gradient maximum | Pulmonary artery main | Cardiac ultrasound


name: Gradient maximum | Right pulmonary artery | Cardiac ultrasound


name: Mean pressure gradient | Patent ductus arteriosis | Cardiac ultrasound


name: Thoughts that you would be better off dead, or of hurting yourself in some way


name: decision support assisted payment decision


name: decision support assisted treatment decision


name: Particle Swarm Optimization with Time Varying Acceleration Coefficient


name: Densely Connected Convolutional Networks


name: Implantable Cardioverter Defibrillator Lead Extraction


name: Cardiovascular Implantable Electronic Device Lead Extraction


name: Developmental Origins of Health and Disease


name: Historically Black Colleges and Universities


name: Health Care Facilities, Womanpower and Services


name: Controlled Human Infection Models as Topic


name: Deep Learning-Based Object Detection Algorithms


name: Arterial Spin Labeling Perfusion Weighted Imaging


name: Grocery and General Merchandise Store Cashiers


name: Equate Children's Multivitamin Gummies (Assorted Fruit)


name: BD Posiflush SafeScrub Saline 0.9% Prefilled Syringe Solution for Injection


name: MAD Nasal Intranasal Mucosal Atomization Device


name: MiniMed Silhouette Infusion Set 13mm-18inch


name: MiniMed Silhouette Infusion Set 13mm-23inch


name: MiniMed Silhouette Infusion Set 13mm-32inch


name: MiniMed Silhouette Infusion Set 13mm-43inch


name: MiniMed Silhouette Infusion Set 17mm-23inch


name: MiniMed Silhouette Infusion Set 17mm-32inch


name: MiniMed Silhouette Infusion Set 17mm-43inch


name: MiniMed Sure-T Infusion Set 29G-10mm-32inch


name: PediaSure SideKicks High Protein Shake (Vanilla)


name: Publix UltiGuard Safe Pack Micro 32G 5/32 inch Pen Needle & Sharps Container


name: Publix UltiGuard Safe Pack Mini 32G 1/4 inch Pen Needle & Sharps Container


name: Similac Expert Care Alimentum Ready-to-Feed Suspension


name: Similac Expert Care Alimentum With Iron Powder For Suspension


name: Similac PM 60/40 Low-Iron Infant Formula Powder for Suspension


name: Similac Pure Bliss Organic with A2 Milk with Iron Powder for Suspension


name: Similac Pure Bliss Organic with Iron Ready-to-Feed Suspension


name: Similac Pure Bliss with Iron Organic Powder for Suspension


name: Walgreens Certainty Men's ComfortLux Underwear (XL)


name: iLet Inset Insulin Infusion Kit 6MM-32 inch


name: Foster & Thrive Early Result Pregnancy Test


name: Glucerna Original CarbSteady Snack Shake (Rich Chocolate)


name: Ensure Active Heart Health Nutrional Shake (Vanilla)


name: Ensure High Protein Nutrition Shake (Milk Chocolate)


name: Ensure MAX Protein Nutrition Shake (Milk Cholcolate)


name: CVS True Metrix Self-Monitoring Premium Blood Glucose Test Strip


name: BIOLYTE Electrolyte Powder for Solution (Citrus)


name: BIOLYTE Electrolyte Powder for Solution (Melon)


name: {16 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 400 MG Once Weekly Carton]


name: {20 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 500 MG Once Weekly Carton]


name: {24 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 600 MG Once Weekly Carton]


name: Cerave Diabetics Dry Skin Moisturizing Relief, topical cream


name: Bactisure Wound Lavage, 6 g-0.13 g-10 g-2 g/100 mL irrigation solution


name: Cerave Diabetics Dry Skin Moisturizing Relief


name: acetic acid/benzalkonium chloride/ethanol/sodium acetate topical 6 g-0.13 g-10 g-2 g/100 mL irrigation solution


name: sodium hyaluronate topical 10 mg vaginal suppository


name: BosleyMD Revive + Densifying Foam For Men


name: BosleyMD Revive + Densifying Foam For Women


name: Compound W Freeze Off For Kids Wart Remover


name: Compound W Nitrofreeze Wart Removal System


name: L'Oreal Paris Dermo-Expertise Eye Defense


name: Neutrogena Stubborn Acne Ultra-Thin Patches


name: RM Oral Charcoal 360 Whitening Toothbrush


name: RM Oral Charcoal 360 Whitening Toothbrush M


name: RM Oral Whitening Cavity Defense Toothbrushes


name: Scott Paper Towels Fast Absorbing Double Roll


name: Vicks ComfortFlex Thermometer Fever Insight


name: Lotion, Multi Ingredient Topical application Lotion [Skin Therapy Lotion]


name: Formula, Infant Oral Powder for Suspension [Dr. Brown's Good Start SoothePro with Iron]


name: Formula, Infant Oral Powder for Suspension [Gerber Good Start SoothePro with Iron]


name: Formula, Infant Oral Powder for Suspension [Dr. Brown's Good Start GentlePro with Iron]


name: Formula, Infant Oral Powder for Suspension [Dr. Brown's Good Start Soy-easePro]


name: Citronella Oil/Lemongrass Oil/Rosemary Oil 0.6%-0.35%-0.06% Topical application Spray [Nix Lice Prevention]


name: Electrolytes Oral Powder for Solution [Biolyte Electrolyte]


name: Gel, Multi Ingredient Nasal Gel/Jelly [Rhinase X Nasal Gel]


name: Lidocaine 9.6% Topical application Spray [KY Duration for Him]


name: Suspension, Multi Ingredient Oral Suspension [Blues Away]


name: Allantoin/Dimethicone 2.25%-5% Topical application Cream


name: Apremilast;Apremilast 10 MG; 20 MG Oral Tablet


name: Citronella Oil/Lemongrass Oil/Rosemary Oil 0.6%-0.35%-0.06% Topical application Spray


name: Dextromethorphan Hydrobromide;Dextromethorphan Hydrobromide/Doxylamine Succinate 10 MG; 10 MG-6.25 MG Oral Tablet, Chewable


name: Levomefolate Calcium 7.5 MG Oral Capsule


name: TITANIUM DIOXIDE 3 g in 100 g / ZINC OXIDE 12 g in 100 g TOPICAL CREAM


name: ZINC OXIDE 165 mg in 1 g / TITANIUM DIOXIDE 23 mg in 1 g TOPICAL CREAM [Replenix Sheer SPF 50]


name: ZINC OXIDE 12 g in 100 mL TOPICAL LOTION [the beach people SPF 15]


name: ZINC OXIDE 18 g in 100 mL TOPICAL LOTION [the beach people SPF 30]


name: ZINC OXIDE 24 g in 100 mL TOPICAL LOTION [the beach people SPF 50]


name: ZINC OXIDE 9.84 g in 50 mL TOPICAL LOTION


name: TITANIUM DIOXIDE 3.9 g in 100 mL / ZINC OXIDE 3.2 g in 100 mL TOPICAL LOTION [Jack Black]


name: TITANIUM DIOXIDE 30 mg in 1 g / ZINC OXIDE 100 mg in 1 g TOPICAL AEROSOL, FOAM [Proceuticals Private Label by TiZO tinted foaming mineral sunscreen]


name: HOMOSALATE 73 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LIQUID [IT COSMETICS YOUR SKIN BUT BETTER CC PLUS NUDE GLOW Color Correcting Medium Coverage Skin Tint plus Brightening Glow Serum plus Broad Spectrum SPF 40 Sunscreen]


name: STERCULIA URENS WHOLE 1500 mg in 50 mL / ACETYL HEXAPEPTIDE-8 1000 mg in 50 mL / PREZATIDE 1000 mg in 50 mL / PALMITOYL TETRAPEPTIDE-7 1000 mg in 50 mL / ACETYL TETRAPEPTIDE-9 1000 mg in 50 mL / SESAME SEED 1500 mg in 50 mL / HEXAPEPTIDE-9 1000 mg in 50 mL / PALMITOYL PENTAPEPTIDE-4 1000 mg in 50 mL / PEACH 1500 mg in 50 mL TOPICAL CREAM [Stretch Marks cream]


name: ZINC OXIDE 24 g in 100 mL TOPICAL CREAM [FRE Glow ME Lightweight Tinted Moisturizer]


name: TITANIUM DIOXIDE 29 mg in 1 g / OCTINOXATE 70 mg in 1 g / ZINC OXIDE 49 mg in 1 g / OCTISALATE 45 mg in 1 g TOPICAL CREAM [JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Fair Light]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL LIQUID [SANTO REMEDIOS RADIANCE SILKY MINERAL PRIMER SUNSCREEN SPF 42 IVORY]


name: TITANIUM DIOXIDE 65.1 mg in 1 g / OCTINOXATE 67 mg in 1 g / OCTISALATE 40 mg in 1 g TOPICAL CREAM [JUNGSAEMMOOL Essential Skin Nuder Cushion Fair Light]


name: ZINC OXIDE 90 g in 1000 g / TITANIUM DIOXIDE 70 g in 1000 g TOPICAL CREAM [EltaMD UV Physical SPF41]


name: ALLANTOIN 7.5 mg in 1 g TOPICAL CREAM [BioBarrier Renewal Cream]


name: GLYCERIN 10 g in 100 g / NIACINAMIDE 4.725 g in 100 g TOPICAL CREAM [Atti amour Rose Anti-Aging Repair Moisturizing Cream]


name: GLYCERIN 5.96 g in 100 mL / NIACINAMIDE 4 g in 100 mL TOPICAL LIQUID [Atti amour Rose Anti-Aging Repair Serum]


name: GLYCERIN 6 g in 100 mL / NIACINAMIDE 4 g in 100 mL TOPICAL LIQUID [Atti amour Rose Anti-Aging Repair Classic Essence]


name: NIACINAMIDE 6.52 g in 100 g / GLYCERIN 2.24 g in 100 g TOPICAL CREAM [Atti amour Rose Anti-Aging Repair Eye Cream]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Old Spice Sweat Defense Swagger Clear]


name: HOMOSALATE 150 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL LIPSTICK [Clarity Rx Pucker Power lip plumper SPF 30]


name: ZINC OXIDE 145 mg in 1 g / TITANIUM DIOXIDE 75 mg in 1 g TOPICAL LOTION [Essential Sheer SPF 50]


name: ZINC OXIDE 200 mg in 1 g TOPICAL STICK [Thinkbaby Sunscreen SPF 30]


name: ALUMINUM CHLOROHYDRATE 20.9 g in 100 g TOPICAL AEROSOL, SPRAY [Brut Classic Antiperspirant and Deodorant]


name: ALUMINUM CHLOROHYDRATE ANHYDROUS 10 g in 100 g TOPICAL AEROSOL, SPRAY [Sure Regular Antiperspirant and Deodorant]


name: OCTOCRYLENE 0.225 g in 74 mL / ZINC OXIDE 0.236 g in 74 mL / HOMOSALATE 0.188 g in 74 mL / OCTISALATE 0.094 g in 74 mL / TITANIUM DIOXIDE 0.05 g in 74 mL TOPICAL CREAM [Sei Bella Daily UV Defense Broad-Spectrum SPF 25 Sunscreen]


name: OCTOCRYLENE 1 g in 40 mL / OXYBENZONE 0.6 g in 40 mL / AVOBENZONE 1.6 g in 40 mL / OCTISALATE 2 g in 40 mL TOPICAL CREAM [BROTEGE Good Boy Protection SPF 15 and Retinol Daily Moisturizer]


name: TITANIUM DIOXIDE 30 mg in 1 g / ZINC OXIDE 100 mg in 1 g TOPICAL AEROSOL, FOAM [Proceuticals Private Label by TiZO non-tinted foaming mineral sunscreen]


name: ZINC OXIDE 2.94 g in 100 g / TITANIUM DIOXIDE 2.4 g in 100 g / OCTINOXATE 7 g in 100 g TOPICAL CREAM [sMTS Dual HA SUN BLOCK]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [TiZO ULTRA ZINC Non-Tinted SPF 40 MINERAL SUNSCREEN FOR BODY and FACE With Antioxidants C and E]


name: Neomycin Sulfate 25 kg in 25 kg NOT APPLICABLE POWDER


name: ZINC OXIDE 0.25 g in 1 g TOPICAL STICK [KawaKids KawaSun - Premium On-The-Go Mineral Sunscreen SPF 50]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Hanalei Face Moisturizing]


name: Peach Slices 3 Step Acne Starter Kit KIT


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 17 g in 100 g TOPICAL GEL [Gillette ClearShield Wild Rain Clear]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 158 mg in 1 g TOPICAL STICK [Mens Speed Irish Spring Original - AP and Deo]


name: OXYBENZONE 6 g in 100 mL / OCTOCRYLENE 5.5 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / HOMOSALATE 15 g in 100 mL / OCTINOXATE 7.5 g in 100 mL TOPICAL SPRAY [SUN THERAPE SPORT SPF-35]


name: ZINC OXIDE 125 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Body Sunscreen SPF 30]


name: ZINC OXIDE 125 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Daily Facial Sunscreen SPF 30]


name: ZINC OXIDE 154 mg in 1 mL TOPICAL CREAM [SKINRAYS Protective Bounce Butter Broad Spectrum SPF 30 Mineral Sunscreen by Glam up]


name: ZINC OXIDE 17 g in 100 mL TOPICAL CREAM [Round Lab Birch Juice Mild-Up UVLOCK Sunscreen SPF50 Broad Spectrum]


name: ZINC OXIDE 940 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Tinted Sunscreen SPF 30 Deep]


name: ZINC OXIDE 940 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Tinted Sunscreen SPF 30 Light Medium]


name: ZINC OXIDE 940 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Tinted Sunscreen SPF 30 Light]


name: ZINC OXIDE 940 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Tinted Sunscreen SPF 30 Medium Deep]


name: ZINC OXIDE 940 mg in 1 mL TOPICAL LIQUID [Crunchi Sunlight Tinted Sunscreen SPF 30 Medium]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LIQUID [SunPlus SPF 30 Everyday Inspired Broad Spectrum Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LIQUID [SunPlus SPF 50 Everyday Inspired Broad Spectrum Sunscreen]


name: PREZATIDE 0.001 g in 100 mL TOPICAL OIL [Seacall Natural Cedarwood Oil]


name: ZINC OXIDE 117 mg in 1 g TOPICAL CREAM [Scar Gel SPF 35]


name: ZINC OXIDE 18.9 g in 100 mL TOPICAL LOTION [SOLARA SUNCARE - GO VACATION GLOW SPF 30]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL CREAM [Protective Day]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Topcare Everyday Sport Continuous Broad Spectrum SPF 100]


name: TITANIUM DIOXIDE 8.8 g in 100 mL TOPICAL CREAM [MACKENZIES OCEAN SAFE SUNSCREEN]


name: HOMOSALATE 60 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / ZINC OXIDE 80 mg in 1 mL TOPICAL STICK [Standard Procedure Lip Balm SPF 50]


name: OCTOCRYLENE 80 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Standard Procedure SPF 50 Sunscreen]


name: OCTOCRYLENE 10 g in 100 mL / HOMOSALATE 10 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL LOTION [SUNSCREEN 01]


name: TITANIUM DIOXIDE 19.5 g in 100 g / ZINC OXIDE 24 g in 100 g CUTANEOUS POWDER [Aloha mineral block-BRUSH ON MINERAL Powder SUNSCREEN SPF50]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Gillette ClearShield Arctic Ice Clear]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 17 g in 100 g TOPICAL GEL [Gillette ClearShield Arctic Ice Clear]


name: ALUMINUM ZIRCONIUM TRICHLOROHYDREX GLY 20 g in 100 g TOPICAL CREAM [Gillette Clinical Protection Arctic Ice Soft]


name: HOMOSALATE 50 mg in 1 mL / ZINC OXIDE 30 mg in 1 mL TOPICAL LOTION [Beauty Hydrating]


name: digital therapeutics,cognit. behavioral therapy for MDD MISCELL MISCELLANEOUS


name: dimethicone/allantoin 5 %-2.25 % TOPICAL CREAM (GRAM)


name: extracellular matrix (ecm), porcine derived 4 cm X 4 cm X 2 cm TOPICAL SHEET (EA)


name: extracellular matrix (ecm), porcine derived 7 cm X 5 cm X 2 cm TOPICAL SHEET (EA)


name: infant formula, iron/dha/ara/FOS/inulin/Bifidobacterium brev 2.9 gram-4.9 gram-11.4 gram/100 kcal ORAL POWDER (GRAM)


name: nut.tx.impaired digest fxn/fiber 14.8 gram-472 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional supplement/fiber 0.03 gram-1 kcal/mL ORAL LIQUID (ML)


name: ascorbate calcium, magnesium, potassium, sodium


name: cardioplegic solution no.34 (induction 4:1)


name: CATHERIZATION SET,INTERMITTENT 14FR C#28944


name: TRACH TUBE,SZ 9 CUFFLESS SMITHS #101816090


name: SET,INFUSION AUTOSOFT XC TANDEM #1006922


name: CENTRAL LINE DRESSING CHANGE KIT MEDLINE #DYNDC0103


name: DRESSING,SILICONE ISLAND 6IN X 6IN #MSC3366


name: DRESSING,EXUFIBER AG PLUS 8IN X 12IN #603424


name: TUBE FEEDING SET KANGAROO JOEY CARDINAL #BSPFD


name: BRIEF,BARIATRIC UNDERWEAR 5X-LARGE ATTENDS


name: CATHERIZATION SET,FOLEY W/O CATH DYNAREX #4926


name: No history of alcohol withdrawal delirium


name: No history of alcohol withdrawal syndrome


name: Enrollment in prescription medication assistance program declined


name: Referral to prescription medication assistance program


name: Enrollment in prescription medication assistance program


name: Referral to pharmaceutical manufacturer prescription medication assistance program


name: Pediatric cardiothoracic surgery service


name: Adverse reaction to drug absent after medication provocation procedure


name: Uses non-hormonal water-based vaginal gel contraception


name: Provision of payment for benefit program application fee


name: Provision of payment for housing security deposit


name: Provision of payment for real estate broker fee


name: Provision of payment for housing utility activation fee


name: Provision of payment for housing moving cost


name: Provision of payment for housing pest control fee


name: Provision of payment for housing inspection to support housing transition


name: Provision of essential household goods to support housing transition


name: Provision of payment for medically necessary home modification


name: Coordination of resources to address childcare needs


name: Assistance with negotiation of housing lease agreement


name: Education about non-attorney legal advocate


name: Military service member of United States Coast Guard


name: Adequate foundation level digital literacy skills


name: Inadequate foundation level digital literacy skills


name: Preprocedure medical respite care for homelessness


name: Posthospitalization medical respite care for homelessness


name: Referral to health plan case management program


name: Provision of payment for utility arrears


name: Provision of payment for housing mold remediation fee


name: Inadequate digital access due to inadequate internet service in geographical region


name: Physiatric manipulation of nuchal region (procedure)


name: Fluoroscopy guided percutaneous transluminal angioplasty with contrast


name: Material from non-qualified supplier used


name: Manufacturing equipment sterilisation issue


name: Bone marrow haemophagocytic macrophages present


name: Failure of additional condition for nonprescription use


name: Issue with additional condition for nonprescription use


name: Hospital anxiety and depression scale abnormal


name: Neutrophil Fc receptor 1 expression increased


name: Ambulatory pulmonary artery pressure monitoring


name: Transcoronary ablation of septal hypertrophy


name: Hepatic magnetic resonance corrected T1 value


name: Fraudulent prescription attainment from multiple physicians


name: Nerve sparing robot assisted radical prostatectomy


name: Pneumocystis jirovecii sputum PCR positive


name: Multislice spiral computed tomography coronary angiography


name: Magnified chemiluminescent examination of cervix


name: HIV antigen/antibody combination test negative


name: HIV antigen/antibody combination test positive


name: Ultrasound-guided percutaneous needle tenotomy


name: Product administered at compromised administration site


name: Manufacturing laboratory analytical testing method management issue


name: Use of inappropriate cleaning agent in manufacturing


name: Out of specification test results stability


name: Stability protocol deviation not documented


name: Manufacturing facility high efficiency air filter issue


name: Implantable cardioverter defibrillator battery replacement


name: Health assessment questionnaire score decreased


name: Health assessment questionnaire score increased


name: Database system product information issue


name: Sodium 18F-fluoride positron emission tomography


name: History of traumatic brain injury (situation)


name: ALUMINUM CHLOROHYDRATE 45 mg in 1 mL TOPICAL LOTION [ZONSEN Roll-On Antiperspirant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 10.24 g in 64 g TOPICAL STICK [Alloy Antiperspirant and Deodorant]


name: HOMOSALATE 7 mg in 50 mL TOPICAL CREAM [dAlba Vegan Tone-Up Sunscreen]


name: HOMOSALATE 9 mg in 50 mL TOPICAL CREAM [dAlba Vegan Essence Sunscreen]


name: HOMOSALATE 9.5 mg in 19 g TOPICAL CREAM [dAlba Vegan Fresh Sun Stick]


name: OCTOCRYLENE 13.04 g in 163 mL / OCTISALATE 8.15 g in 163 mL / AVOBENZONE 4.89 g in 163 mL / HOMOSALATE 24.45 g in 163 mL TOPICAL SPRAY [Sun Shades Sunscreen Sunscreen SPF 50]


name: ZINC OXIDE 18.5 g in 100 mL TOPICAL OIL [Good Karma Dry Oil Mineral Sunscreen SPF-30]


name: ZINC OXIDE 19 mg in 50 mL TOPICAL CREAM [dAlba Vegan Mild Sunscreen]


name: ZINC OXIDE 4.2 g in 100 mL / TITANIUM DIOXIDE 2.45 g in 100 mL TOPICAL LOTION [VEIL MINERAL PRIMER SUNSCREEN BROAD SPECTRUM SPF 15]


name: ZINC OXIDE 11.58 mg in 25 g TOPICAL SPONGE [dAlba Vegan Fresh Sun Cushion]


name: ZINC OXIDE 152.9 mg in 1 g TOPICAL CREAM [SUDOCREM SKIN PROTECTANT]


name: ALUMINUM CHLOROHYDRATE 45 mg in 1 mL TOPICAL LOTION [DawnMist Antiperspirant]


name: ALUMINUM CHLOROHYDRATE 78 mg in 1 mL TOPICAL LOTION [DawnMist Antiperspirant]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL STICK [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50 Plus]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 73.4 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [Hydrating Aloe Rich Suncare SPF 15 Broad Spectrum Very Water Resistant 80 minutes UVA UVB Protection]


name: Avobenzone 30 mg in 1 g / Homosalate 150 mg in 1 g / Meradimate 50 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 100 mg in 1 g TOPICAL GEL [Biocorneum]


name: OCTINOXATE 0.0065 g in 1 g / OCTISALATE 0.005 g in 1 g / OCTOCRYLENE 0.0015 g in 1 g / AVOBENZONE 0.002 g in 1 g TOPICAL LIPSTICK [Lip Balm SPF 15]


name: OCTINOXATE 67 mg in 1 mL / TITANIUM DIOXIDE 46 mg in 1 mL TOPICAL LIQUID [LOreal Paris Infallible UP TO 32H Fresh Wear Foundation Broad Spectrum SPF 25 Sunscreen]


name: OCTINOXATE 75 g in 1000 g / OCTISALATE 30 g in 1000 g / ZINC OXIDE 80 g in 1000 g TOPICAL CREAM [Mimosa Lane SPF45]


name: OCTOCRYLENE 8 g in 100 g / OCTISALATE 4 g in 100 g TOPICAL LIPSTICK [SPF15 lip balm 01]


name: TITANIUM DIOXIDE 40 mg in 1 g / ZINC OXIDE 55 mg in 1 g TOPICAL STICK [Proceuticals Private Label by TiZO non-tinted mineral sunscreen stick]


name: ZINC OXIDE 25 g in 100 mL TOPICAL LOTION [ITP DAILY BAWSE CLEAN, TINTED SUNSCREEN SERUM SPF 28 DEW YOU]


name: DIMETHICONE 0.56 g in 28 g TOPICAL GEL [V Relief Serum]


name: DIMETHICONE 0.56 g in 28 g TOPICAL LOTION [Daily VLotion]


name: LIDOCAINE HYDROCHLORIDE 4 g in 100 mL TOPICAL LIQUID [Bactine Max Bandage]


name: ZINC OXIDE 120 mg in 1 mL TOPICAL LOTION [RMS SUNCOVERUP SUPER TINT SPF 50 ALABASTER]


name: ZINC OXIDE 90 mg in 1 mL / OCTINOXATE 75 mg in 1 mL TOPICAL CREAM [Skin Medicinals SM Clear Broad Spectrum SPF 50]


name: Lice, Bedbug and Mite, 0.5% topical spray


name: MediHoney Wound and Burn Dressing, topical paste


name: Biolyte Berry, oral powder for reconstitution


name: Biolyte Citrus, oral powder for reconstitution


name: Biolyte Melon, oral powder for reconstitution


name: Biolyte Punch, oral powder for reconstitution


name: Biolyte Tropical, oral powder for reconstitution


name: CeraVe Hydrating Facial Cleanser, topical soap


name: BD Veo Ins Syr 6mmx31G 3/10 mL Half-unit scal


name: Formula, Infant Oral Powder for Suspension [Pure Bliss Organic A2 w/Iron]


name: Formula, Infant Oral Powder for Suspension [Pure Bliss Organic w/Iron]


name: Formula, Infant Oral Suspension [Pure Bliss Organic with Iron]


name: ZINC OXIDE 250 mg in 1 mL TOPICAL LOTION [KawaKids KawaSun - Premium Mineral Sunscreen SPF 50]


name: FEEDING SET,ENTERAL PUMP ENFIT MEDLINE#ENFIT70555


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR X-LARGE TENA


name: DRESSING,CUTIMED SORBACT HYDROGEL 3INX6IN


name: CATHERIZATION SET,INTERMITTENT 10FR C#28520-FEMALE


name: CATHERIZATION SET,FOLEY W/ CATH 18FR 10ML BARD #A947318


name: TUBE FEEDING SET,EXTENSION ENFIT AMT #8-1211-ISOSAF


name: TUBE FEEDING SET KANGAROO OMNI CARDINAL #BSPFD


name: IMATINIB 1 g in 1 g NOT APPLICABLE POWDER


name: {1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML / doxylamine succinate 0.625 MG/ML Oral Suspension) / 1 (dextromethorphan hydrobromide 1 MG/ML / guaifenesin 20 MG/ML Oral Suspension) } Pack


name: polyhexamethylene biguanide/gauze bandage 0.2 %-2" X 2" TOPICAL BANDAGE


name: syringe with needle, insulin, safety, 0.5 mL 30 gauge X 1/2" MISCELL SYRINGE, EMPTY DISPOSABLE


name: digital therapeutics,cognit. behavioral therapy for CLBP MISCELL MISCELLANEOUS


name: PCCA PLO-Diclogel Base for Compounding [Bulk Chemical]


name: Clever Choice Comfort EZ Ultra Short Needle 1/2mL 31G 1/4 inch Insulin Syringe


name: Clever Choice Comfort EZ Ultra Short Needle 1mL 31G 1/4 inch Insulin Syringe


name: Clever Choice Comfort EZ Ultra Short Needle 3/10mL 31G 1/4 inch Insulin Syringe


name: POLIGRIP Extra Strength Denture Adhesive Powder


name: ProCheck Bluetooth Blood Pressure Monitor


name: RITE AID Deluxe Douche Combination System


name: Embrace WAVE Self Monitoring Blood Glucose Test Strip


name: Embrace WAVE+ Self Monitoring Blood Glucose Meter


name: Medisca Powder Insufflator For Capsules Size 4


name: AeroChamber Plus Flow-Vu Valved Inhalation Chamber


name: AeroChamber Plus Flow-Vu Valved Inhalation Chamber (Intermediate)


name: AerobiKA Oscillating Positive Expiratory Pressure Device


name: AerobiKA Oscillating Positive Expiratory Pressure Therapy System


name: AMB Anti Friction Body Powder with Calamine Topical Powder


name: CERTAIN DRI Clinical Strength 20% Antiperspirant Deodorant Stick (Morning Fresh)


name: BIOLYTE Electrolyte Powder for Solution (Berry)


name: BIOLYTE Electrolyte Powder for Solution (Tropical)


name: PediaSure Grow & Gain with Fiber Therapeutic Nutrition (Vanilla Shake)


name: ZINC OXIDE 8.7 g in 100 g TOPICAL STICK [doTERRA sun Lip Balm Mineral Sunscreen]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Cancer Council Invisible Fluid SPF50 Plus]


name: TITANIUM DIOXIDE 40 mg in 1 g / ZINC OXIDE 55 mg in 1 g TOPICAL STICK [Proceuticals Private Label by TiZO tinted mineral sunscreen stick]


name: ZINC OXIDE 10.4 g in 40 mL TOPICAL CREAM [Sunscreen for Face SPF50]


name: ZINC OXIDE 144 mg in 1 mL / TITANIUM DIOXIDE 66 mg in 1 mL TOPICAL LOTION [Neutrogena Mineral Ultra Sheer Face SPF 70]


name: ZINC OXIDE 18.9 g in 80 mL TOPICAL CREAM [Sunscreen SPF50]


name: ZINC OXIDE 21.2 g in 80 mL TOPICAL CREAM [Sunscreen for kids SPF50]


name: ZINC OXIDE 0.57 g in 15 mL TOPICAL CREAM [S.O.S Cream Intensive Moisturizing Skin Protectant]


name: ZINC OXIDE 1.55 g in 80 mL TOPICAL CREAM [AfterSun]


name: ALLANTOIN 5 mg in 1 g TOPICAL GEL [Manuka Honey Extra Strength]


name: OCTOCRYLENE 90 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL OIL [Bali Body Pineapple Tanning Oil SPF15]


name: ALUMINUM CHLORIDE 4.35 mg in 30 mL TOPICAL SPRAY [Antiperspirant ODABAN]


name: OCTINOXATE 6 mg in 1 mL TOPICAL CREAM [Note Mattifying Extreme Wear Foundation 02 Natural Beige]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Bloomeffects Tulipscreen Hydrating Lip Oil]


name: ZINC OXIDE 39.2 mg in 1 g / OCTINOXATE 25 mg in 1 g TOPICAL STICK [CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 BERRY CREAMY]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [sunscreen]


name: TITANIUM DIOXIDE 4.95 g in 100 g / ZINC OXIDE 9.5 g in 100 g TOPICAL LOTION [Natural Mineral Sunscreen]


name: HOMOSALATE 4.5 g in 50 mL / OCTISALATE 2.25 g in 50 mL / AVOBENZONE 1.35 g in 50 mL TOPICAL CREAM [THANK YOU FARMER Sun Project Soothing]


name: OCTISALATE 2.25 g in 50 mL / OCTINOXATE 3.4 g in 50 mL / OCTOCRYLENE 2 g in 50 mL / AVOBENZONE 1.35 g in 50 mL / HOMOSALATE 4.5 g in 50 mL TOPICAL CREAM [Sun Project Moisture]


name: TECHNETIUM TC-99M SULFUR COLLOID 10 mCi in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Kit for the Prepartion of Technetium Tc99m Sulfur Colloid]


name: ZINC OXIDE 11.12 g in 50 mL TOPICAL CREAM [THANK YOU FARMER Sun Project Rice Tinted Mineral Sun Cream]


name: ZINC OXIDE 165 mg in 1 g TOPICAL STICK [Ciele Sculpt and Protect]


name: ZINC OXIDE 17.5 g in 100 g TOPICAL CREAM [OS-01 Face SPF BS SPF30 Tinted]


name: ALLANTOIN 1.5 g in 100 g TOPICAL CREAM [BioBarrier Repair Eye Cream]


name: OCTINOXATE 6 mg in 1 mL TOPICAL CREAM [Note BB 100 Porcelain]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Crystal Clear Flawless Clear Clean]


name: CAPSAICIN 0.25 g in 100 g TOPICAL CLOTH [Nufabrx Medicine Infused Wrist Sleeve]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Cancer Council Protect and Hydrate Radiance SPF50 Plus]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cancer Council Daily Body Moisturizer SPF50 Plus]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL PASTE [GLC OG Natural Tinted SPF 30 Sunscreen]


name: HOMOSALATE 13.5 g in 100 mL / OCTISALATE 4.5 g in 100 mL / AVOBENZONE 2.7 g in 100 mL TOPICAL CREAM [ROUND LAB BIRCH JUICE MOISTURIZING UVLOCK SUNSCREEN SPF45 BROAD SPECTRUM]


name: OCTOCRYLENE 1 g in 50 g / ZINC OXIDE 2.5 g in 50 g / TITANIUM DIOXIDE 1 g in 50 g TOPICAL CREAM


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Brown Sugar Clear]


name: ZINC OXIDE 1.182 mg in 30 mL / TITANIUM DIOXIDE 1.734 mg in 30 mL / OCTOCRYLENE 0.9 mg in 30 mL TOPICAL CREAM


name: ZINC OXIDE 5 g in 30 mL / TITANIUM DIOXIDE 5 g in 30 mL TOPICAL CREAM [YOUNG CLARITI BY BIO UTH Mineral Brightening Sheer Tint BROAD SPECTRUM SPF 20]


name: ZINC OXIDE 9.6 g in 50 mL / TITANIUM DIOXIDE 1.56 g in 50 mL TOPICAL CREAM [TIBENA EVERY DAY REAL SUN BLOCK]


name: ETHYLHEXYL TRIAZONE 1.5 mg in 50 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 2.5 mg in 50 mL TOPICAL ELIXIR [Pfect A solar barrier Serum Textured]


name: GARDEN SNAIL MUCIN 58500 mg in 130 g / ASIAN GINSENG 2600 mg in 130 g / COLLAGEN, SOLUBLE, FISH SKIN 2600 mg in 130 g / TOCOPHEROL 1300 mg in 130 g / ASCORBIC ACID 1300 mg in 130 g TOPICAL CREAM [AOA0 Snail Ginseng Cream]


name: OATMEAL 1 mg in 100 g TOPICAL GEL [Whipped Gel]


name: ZINC OXIDE 160 mg in 1 g TOPICAL CREAM [Proceuticals Private Label by TiZO non-tinted replenishing daily protection]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 5 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL SPRAY [Golden Sunglaze Sheer Body Mist Sunscreen SPF50]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / HOMOSALATE 5 mg in 1 mL TOPICAL SPRAY [Sunglaze Sheer Setting Mist Sunscreen SPF50]


name: ZINC OXIDE 23.8 g in 100 g TOPICAL STICK [Pure Protect Mineral Sunscreen Stick SPF50]


name: ALPHA-ARBUTIN 4 g in 100 mL / TOCOPHEROL 2 g in 100 mL / NIACINAMIDE 2 g in 100 mL / GLUTATHIONE 4 g in 100 mL / NEPIDERMIN 2 g in 100 mL TOPICAL LIQUID [ST.LAWRENCE ANTI-AGING AND WHITENING MASK]


name: MARINE COLLAGEN, SOLUBLE 3 g in 100 mL / TOCOPHEROL 3 g in 100 mL / NIACINAMIDE 2 g in 100 mL / NEPIDERMIN 2 g in 100 mL TOPICAL LIQUID [ST.LAWRENCE POLYPEPTIDE COLLAGEN WHITENING FACIAL MASK]


name: ALUMINUM CHLOROHYDRATE 45 mg in 1 mL TOPICAL LIQUID [ZONSEN Antiperspirant]


name: ALUMINUM CHLOROHYDRATE 78 mg in 1 mL TOPICAL LOTION [ZONSEN Roll-On Antiperspirant]


name: AVOBENZONE 25 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL LOTION [Tiege Hanley AM Morning Facial Moisturizer with SPF 20]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 50 Sunscreen]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL AEROSOL, SPRAY [HAWAIIAN TROPIC]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 9 g in 100 mL TOPICAL LOTION [Olay Complete Plus Daily Facial Moisturizer with Sunscreen Broad Spectrum SPF 40]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 2.6 g in 100 mL TOPICAL LOTION [Olay Total Effects Advanced Facial Moisturizer with Sunscreen Broad Spectrum SPF 15 Fragrance-Free]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL SPRAY [Target Up and Up SPF 70 Sport Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 30 Sport Sunscreen]


name: ZINC OXIDE 206 mg in 1 g TOPICAL SPRAY [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen]


name: ZINC OXIDE 206 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen Stick]


name: ZINC OXIDE 6.35 g in 50 mL / OCTISALATE 2.25 g in 50 mL / TITANIUM DIOXIDE 1.1 g in 50 mL / HOMOSALATE 3.75 g in 50 mL TOPICAL CREAM [Dr.Oracle AIR FIT DEFENSE SOOTHING SUNSCREEN]


name: {1 (acetaminophen 32 MG/ML / dextromethorphan hydrobromide 0.5 MG/ML Oral Suspension) / 1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML Oral Suspension) } Pack


name: {1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Suspension) / 1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML / doxylamine succinate 0.625 MG/ML Oral Suspension) } Pack


name: Synchronous Audio-Video Evaluation and Management Services


name: Synchronous Audio-Video Evaluation and Management Services - New Patient


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with straightforward medical decision making, if using time 15 minutes or more


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with low medical decision making, if using time 30 minutes or more


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with moderate medical decision making, if using time 45 minutes or more


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with high medical decision making, if using time 60 minutes or more


name: Synchronous Audio-Video Evaluation and Management Services - Established Patient


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with straightforward medical decision making, if using time 10 minutes or more


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with low medical decision making, if using time 20 minutes or more


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with moderate medical decision making, if using time 30 minutes or more


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with high medical decision making, if using time 40 minutes or more


name: Synchronous Audio-Only Evaluation and Management Services


name: Synchronous Audio-Only Evaluation and Management Services - New Patient


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with straightforward medical decision making and 10 minutes or more of medical discussion, if using time 15 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and straightforward medical decision making, with more than 10 minutes of medical discussion. If using time, at least 15 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with low medical decision making and 10 minutes or more of medical discussion, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and low medical decision making, with more than 10 minutes of medical discussion. If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with moderate medical decision making and 10 minutes or more of medical discussion, if using time 45 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and moderate medical decision making, with more than 10 minutes of medical discussion. If using time, at least 45 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with high medical decision making and 10 minutes or more of medical discussion, if using time 60 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and high medical decision making, with more than 10 minutes of medical discussion. If using time, at least 60 minutes of total time on the encounter date must be met.


name: Synchronous Audio-Only Evaluation and Management Services - Established Patient


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 10 minutes must be exceeded.


name: Established patient synchronous audio-only visit with straightforward medical decision making and 10 minutes or more of medical discussion, if using time 10 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and straightforward medical decision making, with more than 10 minutes of medical discussion. If using time, at least 10 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with low medical decision making and 10 minutes or more of medical discussion, if using time 20 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and low medical decision making, with more than 10 minutes of medical discussion. If using time, at least 20 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with moderate medical decision making and 10 minutes or more of medical discussion, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and moderate medical decision making, with more than 10 minutes of medical discussion. If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with high medical decision making and 10 minutes or more of medical discussion, if using time 40 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and high medical decision making, with more than 10 minutes of medical discussion. If using time, at least 40 minutes of total time on the encounter date must be met.


name: Brief Synchronous Communication Technology Service (eg, Virtual Check-In)


name: Established patient brief communication technology-based service with 5-10 minutes of medical discussion


name: Brief communication technology-based service (eg, virtual check-in) by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related evaluation and management service provided within the previous 7 days nor leading to an evaluation and management service or procedure within the next 24 hours or soonest available appointment, 5-10 minutes of medical discussion


name: Initial hospital inpatient or observation care with moderate level of medical decision making. If using time, 55 minutes or more


name: Initial hospital inpatient or observation care with high level of medical decision making, if using time, 75 minutes or more


name: Subsequent hospital inpatient or observation care with high level of medical decision making, if using time, 50 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with straightforward or low level of medical decision making, if using time, 45 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with moderate level of medical decision making, if using time, 70 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with high level of medical decision making, if using time, 85 minutes or more


name: Hospital inpatient or observation discharge day management, 30 minutes or less


name: Hospital inpatient or observation discharge day management, more than 30 minutes


name: Office or other outpatient consultation with straightforward medical decision making, if using total time, 20 minutes or more


name: Office or other outpatient consultation with low level of medical decision making, if using time, 30 minutes or more


name: Office or other outpatient consultation with moderate level of medical decision making, if using time, 40 minutes or more


name: Office or other outpatient consultation with high level of medical decision making, if using time, 55 minutes or more


name: Inpatient or observation consultation with straightforward medical decision making, if using time, 35 minutes or more


name: Inpatient or observation consultation with low level of medical decision making, if using total time, 45 minutes or more


name: Inpatient or observation consultation with moderate level of medical decision making, if using time, 60 minutes or more


name: Inpatient or observation consultation with high level of medical decision making, if using time, 80 minutes or more


name: Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month


name: Complex chronic care management services for two or more chronic conditions, each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month


name: Harvest of skin for skin cell suspension autograft


name: Harvest of skin for skin cell suspension autograft; first 25 sq cm or less


name: Harvest of skin for skin cell suspension autograft; each additional 25 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Harvest of skin for skin cell suspension self skin graft, each additional 25 sq cm


name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration


name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; first 25 sq cm or less of harvested skin


name: Preparation of skin cell suspension self skin graft, first 25 sq cm or less of harvested skin


name: Preparation of skin cell suspension self skin graft, each additional 25 sq cm or less of harvested skin